CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schottenfeld, D.
Right arrow Articles by Beebe-Dimmer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schottenfeld, D.
Right arrow Articles by Beebe-Dimmer, J.
Related Collections
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Screening, Behavior, and Survivorship
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 2049-2055, November 2006
© 2006 American Association for Cancer Research


Review

Alleviating the Burden of Cancer: A Perspective on Advances, Challenges, and Future Directions

David Schottenfeld and Jennifer Beebe-Dimmer

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan

Requests for reprints: David Schottenfeld, Department of Epidemiology, University of Michigan, 109 Observatory Street, Ann Arbor, MI 48109-2029. Phone: 734-647-3217; Fax: 734-764-3192. E-mail: daschott{at}umich.edu

The control of the burden of cancer would be achievable by promoting health-maintaining lifestyle behavioral practices in conjunction with facilitated access to affordable and effective periodic screening and early detection examinations combined with comprehensive treatment services. In a global population exceeding six billion in the year 2002, there were ~10.9 million new cancer cases, 6.7 million cancer deaths, and 22.4 million persons surviving from cancer diagnosed in the previous 5 years. In 2020, the world's population is projected to increase to 7.5 billion and will experience 15 million new cancer cases and 12 million cancer deaths. This perspective on advances, challenges, and future directions in cancer epidemiology and prevention reviews the conceptual foundation for multistep carcinogenesis, causal mechanisms associated with chronic inflammation and the microenvironment of the cancer cell, and obesity, energy expenditure, and insulin resistance. Strategic priorities in global cancer control initiatives should embrace these fundamental concepts by targeting tobacco and alcohol consumption, the increasing prevalence of obesity and metabolic sequelae, and persistent microbial infections. (Cancer Epidemiol Biomarkers Prev 2006;15(11):2049–55)




This article has been cited by other articles:


Home page
CA Cancer J ClinHome page
S. S. Coughlin
Surviving Cancer or Other Serious Illness: A Review of Individual and Community Resources
CA Cancer J Clin, January 1, 2008; 58(1): 60 - 64.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Kuller
Is Phenomenology the Best Approach to Health Research?
Am. J. Epidemiol., November 15, 2007; 166(10): 1109 - 1115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.